Heron Therapeutics | HRTX - Stock

Heron Therapeutics reported $54.57M in Stock for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Stock Change
ALKERMES ALKS:US USD 181.42M 15.12M
Alnylam Pharmaceuticals ALNY:US USD 128.96M 13.47M
Amarin AMRN:US USD 227.61M 1.83M
Ani Pharmaceuticals ANIP:US USD 105.35M 9.46M
Anika Therapeutics ANIK:US USD 39.76M 2.53M
Eisai 4523:JP JPY 120.86B 6.45B
Emergent Biosolutions EBS:US USD 351.8M 194.5M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Esperion Therapeutics ESPR:US USD 35.2M 5.66M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Heron Therapeutics HRTX:US USD 54.57M 2.33M
Insmed INSM:US USD 69.92M 3.65M
JAZZ PHA JAZZ:US USD 714.06M 14.01M
Ligand Pharmaceuticals LGND:US USD 13.29M 9.03M
Nektar Therapeutics NKTR:US USD 19.2M 145K
Pacira Pharmaceuticals PCRX:US USD 96.06M 736K
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Roche Holding ROG:VX 8.6B 313M
Teva Pharmaceutical Industries TEVA:US USD 3.83B 26M
Ultragenyx Pharmaceutical RARE:US USD 26.77M 4.92M
Veracyte VCYT:US USD 14.29M 496K
Vertex Pharmaceuticals VRTX:US USD 460.6M 72.4M